SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Dr Lal Pathlabs

BSE: 539524 19 Aug 2025
Healthcare
₹ 3382.35
Dr. Lal Pathlabs Limited specializes in Healthcare Service Provider within the Healthcare sector.

Dr Lal Pathlabs - Share Price & Details

Market Cap
₹28,381
High /Low
3,654 / 2,294
Stock P/E
55.3
Book Value
₹260.0
Dividend Yield
0.71
ROCE
28.9
ROE
₹24.3
Face Value
10.0
PEG Ratio
4.5
EVEBITDA
₹33.8
Debt
157
CMP / FCF
60.5
Debt to equity
₹0.07
NP Ann
492
High price all time
4,246
Piotroski score
₹8.0
Graham Number
599.0
No. Eq. Shares
8.38
Net CF
₹-68.3
Net profit
518
Price to book value
13.0
Interest Coverage
₹32.2
Low price all time
696.0
Industry PE
49.9
Reserves
₹2,089
Free Cash Flow
₹516

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
Dr. Lal Pathlabs Limited6670.01293.06407.015.4928,38155.3
Syngene International Limited8159.0740.07993.01.832752754.3
J.B.CHEMICALS & PHARMACEUTICAL10538.01978.710399.012.482691039.3

Peer Comparison Chart


About Dr Lal Pathlabs

Dr. Lal Pathlabs Limited, with Security Code 539524, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Technical Analysis: Dr. Lal PathLabs Limited (LALPATHLAB) - Proven strategies for superior portfolio growth

(06 Aug 2025)
Technical Analysis: Dr. Lal PathLabs Limited (LALPATHLAB) ✌️【Stock Highlights】✌️ Precise investment guidance and live stock updates for...
Read more →

Dr. Lal PathLabs Limited Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next

(06 Aug 2025)
It's been a good week for Dr. Lal PathLabs Limited ( NSE:LALPATHLAB ) shareholders, because the company has just...
Read more →

Coal India, Dr Lal PathLabs, Ramco Cements, Blue Dart to turn ex-dividend on Wednesday

(06 Aug 2025)
The Coal India board, at its meeting held on July 31, had recommended an interim dividend of Rs 5.5 per equity share.
Read more →

Dr Lal PathLabs Banks On Volume Growth To Achieve 11-12% Revenue Growth In FY26

(06 Aug 2025)
Healthcare diagnostic provider Dr Lal PathLabs maintains FY26 revenue growth guidance at around 11–12%. The top executive explained that the...
Read more →

Dr. Lal PathLabs Limited (LALPATHLAB) Expands into New Market - Consistently exceptional gains

(30 Jul 2025)
Dr. Lal PathLabs Limited (LALPATHLAB) Expands into New Market ✌️【Investor Trends】✌️ Achieve financial goals faster with actionable stock...
Read more →

Dr Lal PathLabs Q1 results: Profit up 24% aided by higher sampling; interim dividend declared

(30 Jul 2025)
Dr Lal PathLabs posted a 24% YoY rise in Q1 profit to ₹132 crore, driven by higher sample volumes. Revenue grew 11.3%, and the board...
Read more →

Company Updates